MMP9 and breast carcinoma: Studies have indicated that EHH can inhibit NF‐κB activity and reduce the expression of TNFα‐induced matrix metalloproteinase (MMP)‐9 mRNA, thereby attenuating the migratory capabilities of breast cancer cells.6